Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents

Area of Science:

• Cardiology
• Biomedical Engineering

Background:

• Cardiovascular disease is a leading global cause of mortality.
• Percutaneous coronary interventions (PCIs) improve patient prognosis alongside medical therapy.
• Coronary stent technology has evolved to address complications like in-stent restenosis and stent thrombosis.

Purpose of the Study:

• To review the historical evolution of coronary drug-eluting stent (DES) platforms.
• To provide an update on clinical studies of current DESs.
• To detail the major characteristics of commonly used DESs.

Main Methods:

• Literature review of coronary stent technology advancements.
• Analysis of clinical studies on first-generation to third-generation DESs.
• Synthesis of data on DES polymer biocompatibility and efficiency.

Main Results:

• DESs have progressed from bare metal stents to advanced, thinner, third-generation platforms.
• Improved polymer biocompatibility in newer DESs enhances efficiency.
• Understanding adverse events has driven DES technological improvements.

Conclusions:

• Coronary stent technology, particularly DESs, has seen continuous innovation.
• Third-generation DESs represent a significant advancement in treating cardiovascular disease.
• Ongoing research refines DES platforms for better clinical outcomes.